Russell Investments Group, Ltd. Repligen Corp Transaction History

Russell Investments Group, Ltd.

  • $66.8 Billion
  • Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Repligen Corp stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 57,503 shares of RGEN stock, worth $8.19 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
57,503
Previous 40,028 43.66%
Holding current value
$8.19 Million
Previous $5.05 Million 69.61%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$119.79 - $167.35 $2.09 Million - $2.92 Million
17,475 Added 43.66%
57,503 $8.56 Million
Q2 2024

Aug 08, 2024
BUY
$120.0 - $182.95 $587,280 - $895,357
4,894 Added 13.93%
40,028 $5.05 Million
Q1 2024

May 08, 2024
BUY
$170.78 - $208.42 $298,181 - $363,901
1,746 Added 5.23%
35,134 $6.46 Million
Q4 2023

Feb 05, 2024
SELL
$114.17 - $185.35 $602,703 - $978,462
-5,279 Reduced 13.65%
33,388 $6 Million
Q3 2023

Nov 13, 2023
SELL
$138.78 - $176.51 $334,321 - $425,212
-2,409 Reduced 5.86%
38,667 $6.15 Million
Q2 2023

Aug 10, 2023
SELL
$138.42 - $180.31 $39,034 - $50,847
-282 Reduced 0.68%
41,076 $5.81 Million
Q1 2023

May 09, 2023
SELL
$154.26 - $198.1 $802,460 - $1.03 Million
-5,202 Reduced 11.17%
41,358 $6.96 Million
Q4 2022

Feb 08, 2023
SELL
$162.42 - $220.56 $1.05 Million - $1.43 Million
-6,481 Reduced 12.22%
46,560 $7.88 Million
Q3 2022

Nov 04, 2022
SELL
$160.42 - $256.21 $600,291 - $958,737
-3,742 Reduced 6.59%
53,041 $9.92 Million
Q2 2022

Jul 29, 2022
SELL
$140.68 - $188.02 $146,869 - $196,292
-1,044 Reduced 1.81%
56,783 $9.22 Million
Q1 2022

May 05, 2022
SELL
$161.19 - $257.96 $1.92 Million - $3.07 Million
-11,887 Reduced 17.05%
57,827 $10.9 Million
Q4 2021

Jan 21, 2022
BUY
$247.59 - $304.47 $1.41 Million - $1.74 Million
5,707 Added 8.92%
69,714 $18.5 Million
Q3 2021

Nov 08, 2021
SELL
$194.77 - $324.21 $3.82 Million - $6.36 Million
-19,613 Reduced 23.45%
64,007 $18.5 Million
Q2 2021

Aug 04, 2021
SELL
$165.87 - $220.95 $23,055 - $30,712
-139 Reduced 0.17%
83,620 $16.7 Million
Q1 2021

May 10, 2021
BUY
$180.37 - $226.26 $3.36 Million - $4.22 Million
18,639 Added 28.62%
83,759 $16.3 Million
Q4 2020

Feb 08, 2021
SELL
$148.08 - $206.57 $4.7 Million - $6.55 Million
-31,725 Reduced 32.76%
65,120 $12.5 Million
Q3 2020

Nov 09, 2020
BUY
$122.51 - $158.27 $1.06 Million - $1.37 Million
8,674 Added 9.84%
96,845 $14.3 Million
Q2 2020

Aug 05, 2020
SELL
$94.33 - $140.48 $2.73 Million - $4.07 Million
-28,965 Reduced 24.73%
88,171 $10.9 Million
Q1 2020

May 06, 2020
BUY
$84.96 - $109.14 $396,678 - $509,574
4,669 Added 4.15%
117,136 $11.3 Million
Q4 2019

Jan 29, 2020
BUY
$73.84 - $93.08 $450,571 - $567,974
6,102 Added 5.74%
112,467 $10.4 Million
Q3 2019

Nov 01, 2019
BUY
$76.65 - $95.51 $944,941 - $1.18 Million
12,328 Added 13.11%
106,365 $8.16 Million
Q2 2019

Aug 09, 2019
SELL
$54.2 - $85.95 $527,962 - $837,238
-9,741 Reduced 9.39%
94,037 $8.08 Million
Q1 2019

May 13, 2019
SELL
$49.45 - $62.8 $98,652 - $125,286
-1,995 Reduced 1.89%
103,778 $6.13 Million
Q4 2018

Feb 11, 2019
SELL
$48.26 - $68.88 $2.81 Million - $4.01 Million
-58,275 Reduced 35.52%
105,773 $5.58 Million
Q3 2018

Oct 26, 2018
SELL
$46.8 - $58.97 $1.32 Million - $1.66 Million
-28,202 Reduced 14.67%
164,048 $9.1 Million
Q2 2018

Aug 08, 2018
SELL
$35.26 - $47.04 $143,226 - $191,076
-4,062 Reduced 2.07%
192,250 $9.04 Million
Q1 2018

May 11, 2018
BUY
$30.92 - $37.27 $2.46 Million - $2.97 Million
79,653 Added 68.28%
196,312 $7.1 Million
Q4 2017

Feb 06, 2018
SELL
$32.53 - $38.92 $200,287 - $239,630
-6,157 Reduced 5.01%
116,659 $4.21 Million
Q3 2017

Nov 07, 2017
BUY
$36.98 - $46.06 $4.54 Million - $5.66 Million
122,816
122,816 $4.71 Million

Others Institutions Holding RGEN

# of Institutions
488
Shares Held
54.3M
Call Options Held
350K
Put Options Held
184K
View Full List

About REPLIGEN CORP

RGEN Quotes by TradingView
  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.9B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email